Melbourne Law School, University of Melbourne, Melbourne, VIC, Australia.
Biomedical Ethics Research Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Twin Res Hum Genet. 2020 Jun;23(3):184-189. doi: 10.1017/thg.2020.51.
In 2020, the Human Genetics Society of Australasia released its Position Statement on Predictive and Presymptomatic Genetic Testing in Adults and Children. This Position Statement synthesizes the major practical, psychosocial and ethical considerations associated with presymptomatic and predictive genetic testing in adults who have the capacity to make a decision, children and young people who lack capacity and adults living with reduced or fluctuating capacity. Recommendations include that predictive testing in adults, young people and children should only be offered with pretest genetic counseling and the option of posttest genetic counseling. An individual considering (for themselves or on behalf of another) whether to have a predictive test should also be supported to allow them to make an autonomous and informed decision. Predictive testing should only be offered to children and young people for conditions where there is likely to be a direct medical benefit to them through surveillance, use of prevention strategies or other medical interventions in the immediate future. Where symptoms are likely to develop in childhood, in the absence of options to implement surveillance or risk reduction measures, genetic health professionals and parents/guardians should discuss whether undertaking predictive testing is the best course of action for the child and the family as a whole. Where symptoms are likely to develop in adulthood, the default position should be to postpone predictive testing until the young person achieves the capacity to make their own autonomous and informed decision.
2020 年,澳大利亚人类遗传学学会发布了《成人和儿童预测性和预发性基因检测立场声明》。本立场声明综合了与有能力做出决策的成人、无能力做出决策的儿童和青少年以及能力降低或波动的成人进行预发性和预测性基因检测相关的主要实际、心理社会和伦理问题。建议包括,只有在进行预检测基因咨询并提供检测后基因咨询的情况下,才能对成人、年轻人和儿童进行预测性检测。考虑(为自己或代表他人)是否进行预测性检测的个人也应得到支持,以使其能够做出自主和知情的决定。只有在对儿童和年轻人进行检测时,才应考虑对他们有直接医疗效益的情况,例如通过监测、使用预防策略或其他医疗干预措施在不久的将来获得直接受益。如果在儿童时期就有可能出现症状,而没有实施监测或降低风险措施的选择,遗传健康专业人员和父母/监护人应讨论对儿童进行预测性检测是否是对儿童和整个家庭最有利的行动方案。如果在成年后可能出现症状,默认的做法应是推迟预测性检测,直到年轻人有能力做出自己的自主和知情决定。